Mehul Dalal

Mehul Dalal is affiliated with the Yale School of Medicine at Yale University, where he contributes to research in hematology and oncology. His work focuses on real-world clinical outcomes and health economics, particularly in higher-risk myelodysplastic syndromes.

Research Interests:

• Hematology and Oncology
• Myelodysplastic Syndromes (MDS)
• Real-World Evidence and Clinical Outcomes
• Health Economics and Cost Analysis
• Translational and Clinical Research

His recent publication analyzes treatment patterns and outcomes across multiple countries, indicating a strong focus on comparative healthcare systems and evidence-based practice in hematologic malignancies. The research integrates epidemiology, clinical data, and economic evaluation to inform treatment strategies and policy.

Scientific Contributions:

• Peer-reviewed research in high-impact medical journals
• Collaborative international studies involving France, Germany, and the UK
• Focus on patient-centered outcomes and healthcare costs

Mehul Dalal is actively involved in clinical investigation and contributes to advancing knowledge in myelodysplastic syndromes. While specific details about mentoring, grants, or teaching are not available, his scholarly output suggests an active role in academic medicine. He is likely involved in multidisciplinary teams focused on hematologic cancers and health services research.